Free Trial
NASDAQ:TOI

Oncology Institute (TOI) Stock Price, News & Analysis

Oncology Institute logo
$3.40 -0.08 (-2.30%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$3.42 +0.02 (+0.74%)
As of 08/29/2025 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Oncology Institute Stock (NASDAQ:TOI)

Key Stats

Today's Range
$3.31
$3.52
50-Day Range
$2.05
$4.28
52-Week Range
$0.13
$4.50
Volume
1.57 million shs
Average Volume
1.85 million shs
Market Capitalization
$317.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Buy

Company Overview

Oncology Institute Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
48th Percentile Overall Score

TOI MarketRank™: 

Oncology Institute scored higher than 48% of companies evaluated by MarketBeat, and ranked 592nd out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Oncology Institute has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Oncology Institute has only been the subject of 2 research reports in the past 90 days.

  • Read more about Oncology Institute's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oncology Institute is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oncology Institute is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Oncology Institute's valuation and earnings.
  • Percentage of Shares Shorted

    12.11% of the float of Oncology Institute has been sold short.
  • Short Interest Ratio / Days to Cover

    Oncology Institute has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oncology Institute has recently decreased by 23.08%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Oncology Institute does not currently pay a dividend.

  • Dividend Growth

    Oncology Institute does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.11% of the float of Oncology Institute has been sold short.
  • Short Interest Ratio / Days to Cover

    Oncology Institute has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oncology Institute has recently decreased by 23.08%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Oncology Institute has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.09 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Oncology Institute this week, compared to 2 articles on an average week.
  • Search Interest

    Only 3 people have searched for TOI on MarketBeat in the last 30 days. This is a decrease of -81% compared to the previous 30 days.
  • MarketBeat Follows

    14 people have added Oncology Institute to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Oncology Institute insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,959,013.00 in company stock.

  • Percentage Held by Insiders

    Only 8.50% of the stock of Oncology Institute is held by insiders.

  • Percentage Held by Institutions

    Only 36.86% of the stock of Oncology Institute is held by institutions.

  • Read more about Oncology Institute's insider trading history.
Receive TOI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TOI Stock News Headlines

This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel
See More Headlines

TOI Stock Analysis - Frequently Asked Questions

Oncology Institute's stock was trading at $0.3090 at the beginning of the year. Since then, TOI stock has increased by 1,000.3% and is now trading at $3.40.

The Oncology Institute, Inc. (NASDAQ:TOI) released its quarterly earnings data on Wednesday, May, 14th. The company reported ($0.18) earnings per share (EPS) for the quarter. The company had revenue of $104.41 million for the quarter. Oncology Institute had a negative trailing twelve-month return on equity of 1,527.21% and a negative net margin of 14.26%.
Read the conference call transcript
.

Oncology Institute's top institutional investors include Tiff Advisory Services LLC (4.07%), Balyasny Asset Management L.P. (2.82%), Marshall Wace LLP (1.66%) and Geode Capital Management LLC (1.43%). Insiders that own company stock include Growth I LP M33, Daniel Virnich, Brad Hively, Richard A Barasch, Mark L Pacala, Matthew P Miller, Yale Podnos, Mohit Kaushal and Havencrest Healthcare Partners.
View institutional ownership trends
.

Shares of TOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncology Institute investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Arista Networks (ANET), Adobe (ADBE), AppLovin (APP) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
5/14/2025
Today
8/31/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:TOI
CIK
1799191
Fax
N/A
Employees
660
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$6.00
Potential Upside/Downside
+105.9%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.68)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$64.66 million
Net Margins
-14.26%
Pretax Margin
-15.56%
Return on Equity
-1,527.21%
Return on Assets
-34.25%

Debt

Debt-to-Equity Ratio
14.58
Current Ratio
1.62
Quick Ratio
1.37

Sales & Book Value

Annual Sales
$393.41 million
Price / Sales
0.81
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.10) per share
Price / Book
-34.00

Miscellaneous

Outstanding Shares
93,500,000
Free Float
85,557,000
Market Cap
$317.90 million
Optionable
Not Optionable
Beta
0.08
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:TOI) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners